These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20560972)

  • 21. Prevention of venous thromboembolism in thoracic and cardiovascular surgery.
    Egawa N; Hiromatsu S; Shintani Y; Kanaya K; Fukunaga S; Aoyagi S
    Asian Cardiovasc Thorac Ann; 2009 Oct; 17(5):505-9. PubMed ID: 19917794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism in patients hospitalized with nephrotic syndrome.
    Kayali F; Najjar R; Aswad F; Matta F; Stein PD
    Am J Med; 2008 Mar; 121(3):226-30. PubMed ID: 18328307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies.
    Patel A; Anraku M; Darling GE; Shepherd FA; Pierre AF; Waddell TK; Keshavjee S; de Perrot M
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):843-8. PubMed ID: 19660355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score.
    Connolly GC; Khorana AA
    Thromb Res; 2010 Apr; 125 Suppl 2():S1-7. PubMed ID: 20433985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
    Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
    Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer in males and risk of venous thromboembolism.
    Beyer-Westendorf J; Werth S; Halbritter K; Weiss N
    Thromb Res; 2010 Apr; 125 Suppl 2():S155-9. PubMed ID: 20433997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous thromboembolism in patients hospitalized with thyroid dysfunction.
    Danescu LG; Badshah A; Danescu SC; Janjua M; Marandici AM; Matta F; Yaekoub AY; Malloy DJ; Stein PD
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):676-80. PubMed ID: 19671566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
    Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Di Micco P; Iannuzzo M; Lecumberri R; Guijarro R; Madridano O; Monreal M;
    Thromb Haemost; 2008 Nov; 100(5):905-11. PubMed ID: 18989537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
    Folkeringa N; Coppens M; Veeger NJ; Bom VJ; Middeldorp S; Hamulyak K; Prins MH; Büller HR; van der Meer J
    Thromb Haemost; 2008 Jul; 100(1):38-44. PubMed ID: 18612536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.
    Khorana AA; Francis CW; Culakova E; Kuderer NM; Lyman GH
    Cancer; 2007 Nov; 110(10):2339-46. PubMed ID: 17918266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidental venous thromboembolism in cancer patients: prevalence and consequence.
    Douma RA; Kok MG; Verberne LM; Kamphuisen PW; Büller HR
    Thromb Res; 2010 Jun; 125(6):e306-9. PubMed ID: 20223502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Deep venous thrombosis and neoplastic pathology: our experience in emergencies].
    Schillaci F; Stagnitti F; Iurato C; Mongardini M; Dall'olio D; Salvi PF; Cazzaniga M; Bresadola L; Schultze W; Natalini E
    G Chir; 1998; 19(6-7):293-300. PubMed ID: 9707837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of venous thrombosis.
    López JA; Chen J
    Thromb Res; 2009; 123 Suppl 4():S30-4. PubMed ID: 19303501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
    Wun T; White RH
    Cancer Invest; 2009; 27 Suppl 1():63-74. PubMed ID: 19291526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying cancer patients at risk for venous thromboembolism.
    Sousou T; Khorana A
    Hamostaseologie; 2009 Jan; 29(1):121-4. PubMed ID: 19151861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification for cancer-associated venous thromboembolism.
    Connolly GC; Khorana AA
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):35-47. PubMed ID: 19285271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.